Stocks
Intra-Cellular Therapies (ITCI) P/FCF US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -14.7 | -9.71 | -16.4 | -18.4 | -55.2 | -88.0 | |||
| Changes by years, y/y, % | +180% | -34% | +68% | +12% | +200% | +60.0% | |||
Intra-Cellular Therapies. P/FCF
Intra-Cellular Therapies. P/FCF, changes, %
Intra-Cellular Therapies (ITCI) P/FCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/FCF | -31.0 | -55.4 | -68.0 | -116.0 | -123.0 | -88.0 | ||
| Changes by years, y/y, % | +115% | +199% | +227% | +262% | +297% | |||
| Changes by quarters, q/q, % | -3% | +79% | +23% | +71% | +6% | |||
